CLSA Co-Hosts Congressional Briefing on Importance of Intellectual Property in Advancing Global Health
By Jenny Nieto
Sept. 15, 2018
On Sept. 11, CLSA co-hosted a multi-state life sciences association Congressional briefing on the patent system and how it works toward encouraging innovation in the development of life-saving technologies. The discussion also focused on the risks associated with weakening IP protections, specifically those risks faced by patients. In collaboration with Rep. Leonard Lance (R-NJ) and Rep. Scott Peters (D-San Diego) as co-chairs of the Congressional Life Science Caucus, CLSA co-hosted the event with more than a dozen other state and regional life sciences associations.
CLSA assisted in securing the expert panelists, including representatives from the Center for the Protection of Intellectual Property (CPIP) at George Mason University, the U.S. Chamber of Commerce’s Global Innovation Policy Center, Novartis Pharmaceuticals, and the Association of University Technology Managers (AUTM).
CLSA continues to support efforts to strengthen IP protections and encourage innovation in the life sciences ecosystem. Similarly, we also continue to educate lawmakers on the value of strong patent laws and the dangers of breaking down those protections. CLSA is supportive of H.R. 5340, the STRONGER Patents Act, legislation that would curb abusive patent litigation practices while maintaining and strengthening important patent-holder rights and protections, as well as draft legislation, the Hatch-Waxman Integrity Act of 2018, which would protect the ability of drug companies to develop low-cost drugs while at the same time ensuring innovative products have sufficient protections in place to recoup their investments. CLSA is opposed to proposals that undermine intellectual property for innovative medical technologies, including H.R. 6505, the Medicare Negotiation and Competitive Licensing Act.
Questions? Please contact Jenny Nieto, CLSA’s Vice President, Federal Government Relations & Alliance Development (email@example.com).